Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis
Authors:
- Thierry PoynardTPThierry Poynard
- Jean-Pierre CapronJCJean-Pierre Capron
- Patrick HillonPHPatrick Hillon
- Patrick GeoffroyPGPatrick Geoffroy
- Dominique RoulotDRDominique Roulot
- Jean-Claude ChaputJCJean-Claude Chaput
- Bernard RueffBRBernard Rueff
- Jean-Pierre BenhamouJBJean-Pierre Benhamou
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 7 (1) , 118-125
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertensionAmerican Heart Journal, 1984
- A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final ReportHepatology, 1984
- Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.Gut, 1984
- Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.Gut, 1984
- Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with CirrhosisNew England Journal of Medicine, 1983
- The Effect of Propranolol on Portal Hypertension in Patients With Cirrhosis: A Hemodynamic StudyHepatology, 1982
- Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with CirrhosisNew England Journal of Medicine, 1981
- PROPRANOLOL—A MEDICAL TREATMENT FOR PORTAL HYPERTENSION?The Lancet, 1980
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973